Navigation Links
Personalized Medicine Makes Its Way to Pets With Cancer: Morphogenesis and SEVO-Med Team up for a Canine Cancer Field Study, First of Its Kind, Side-Effect-Free Process to Treat Companion Animals
Date:8/23/2013

Jacksonville, FL and Savannah, GA (PRWEB) August 23, 2013

Morphogenesis Inc., a biotechnology firm that has developed a specialized process that educates the immune system to fight cancer in dogs, cats and horses, announces the start of a field study for its personalized cancer treatment for dogs in partnership with SEVO-Med (Southeastern Veterinary Oncology and Medicine).

Tampa-based Morphogenesis and SEVO-Med, a major southeastern veterinary oncology practice which has clinics in Jacksonville and Savannah, are providing the opportunity to pet owners and veterinarians to enroll dogs with High Grade B Cell Lymphoma who might benefit from this personalized treatment.

The first 20 dogs who qualify for the study will be selected. Veterinarians and dog owners who believe their patient/pet could qualify to participate in the study should immediately contact SEVO-Med at 904-278-3870 or 912-355-5791. Once a dog is accepted into the study, treatments and study tests are provided at no cost to the owner.

The vaccine-based cancer treatments developed by Morphogenesis have been shown to manage 17 types of cancer without any side effects in canine, feline and equine patients.

In the treatment developed by Morphogenesis, the dog’s own lymphoma cells undergo a marking process that helps the animal’s immune system recognize the cells as foreign and kill them.

“We educate the body’s immune system to fight its own tumor cells,” said Pat Lawman, Ph.D., CEO of Morphogenesis. “Our process helps keep the cancer in check so that it doesn't progress, and we all think that’s a win.”

“More and more, you are seeing companion animals present with all types of cancers,” Tracy LaDue, DVM, founder of SEVO-Med, wrote in letters to veterinarians informing them of this treatment option for qualifying dogs. “The study being conducted by Morphogenesis and SEVO-Med will further demonstrate the safety and effectiveness of this cutting edge new technology in the fight against lymphoma.”    

About SEVO-Med

Southeast Veterinary Oncology (SEVO) was founded in the Jacksonville suburb of Orange Park, FL, in October, 2004 by double-board certified veterinary oncologist, Tracy LaDue, DVM. At that time, SEVO was one of the first oncology-specific veterinary specialty practices in the U.S. The practice opened its Savannah, GA, clinic in September of 2011. Today, the practices are led by Dr. LaDue and Jennifer Locke, DVM in Florida, and Andrew Daters, DVM, in Georgia. SEVO-Med’s mission is to understand the unique and special bond shared between you and your pet, to offer compassionate guidance, to deliver excellent state of the art medical care, to provide the utmost in client communication and to collaborate with referring veterinarians to develop the best therapy for your pet. For more information, please visit http://www.petcancercare.com or call 904-278-3870 or 912-355-5791.

About Morphogenesis

Morphogenesis is a privately-held biotechnology company structured to serve the rapidly growing cell therapy, biologics and tissue engineering markets. Morphogenesis has developed a multi-indication cancer therapy which educates the immune system to attack tumor cells throughout the body without damaging other cells or systems. Its subsidiary, Veterinary Oncology Services, Inc., assists veterinary physicians in providing this non-toxic, personalized treatment for many types of cancers in cats, dogs and horses. For more information, please visit http://www.veterinaryoncologyservices.com or 813-877-7896 http://www.morphogenesis-inc.com or call 813-875-6600.

Read the full story at http://www.prweb.com/releases/2013/8/prweb11054809.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. QIAGEN Partners with Exosome Diagnostics to Create High-Performance Biofluid Sample Preparation Kits for Personalized Healthcare Research
2. The International Congress on Personalized Medicine - Up Close and Personalized 2013 in Paris
3. NYSCF scientists create personalized bone substitutes from skin cells
4. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
5. Epizyme Granted First Patent Covering Personalized Therapeutic Drug Candidate E7438
6. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
7. Transplanted brain cells in monkeys light up personalized therapy
8. Research and Markets: Personalized Medicine - Scientific and Commercial Aspects - 2013 Report
9. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research, Co-Invest in Sanguine BioSciences
10. Genomas Expands Personalized Medicine Business with Clinical Laboratory Licenses in New York, Florida, California
11. INVENT Ventures and Heliant Ventures Seek to Accelerate Personalized Medicine Research with Seed Round Investment in Sanguine BioSciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... Lithuania, announced today that they have entered into a multiyear collaboration to identify ... CRISPR researchers with additional tools for gene editing across all applications. , Under ...
(Date:10/12/2017)... ... ... AMRI, a global contract research, development and manufacturing organization ... quality of life, will now be offering its impurity solutions as a stand-alone ... for all new drug products, including the finalization of ICH M7 earlier this ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... ... 11, 2017 , ... Proscia Inc ., a data ... titled, “Pathology is going digital. Is your lab ready?” with Dr. Nicolas Cacciabeve, ... and how Proscia improves lab economics and realizes an increase in diagnostic confidence.* ...
Breaking Biology Technology:
(Date:5/16/2017)... , May 16, 2017  Veratad Technologies, LLC ( ... online age and identity verification solutions, announced today they ... Conference 2017, May 15 thru May 17, 2017, in ... and International Trade Center. Identity impacts ... and in today,s quickly evolving digital world, defining identity ...
(Date:4/24/2017)... , April 24, 2017 Janice ... partner with  Identity Strategy Partners, LLP (IdSP) , ... or without President Trump,s March 6, 2017 ... Entry , refugee vetting can be instilled with greater ... (Right now, all refugee applications are suspended by ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
Breaking Biology News(10 mins):